Valsartan in acute myocardial infarction trial (valiant): rationale and design (2000)
Source: American Heart Journal. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES (EPIDEMIOLOGIA), CARDIOPATIAS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PFEFFER, Marc A. et al. Valsartan in acute myocardial infarction trial (valiant): rationale and design. American Heart Journal, v. 140, n. 5, p. 727-734, 2000Tradução . . Acesso em: 14 ago. 2024.APA
Pfeffer, M. A., McMurray, J., Leizorovicz, A., Maggioni, A. P., Rouleau, J. -L., Van de Werf, F., et al. (2000). Valsartan in acute myocardial infarction trial (valiant): rationale and design. American Heart Journal, 140( 5), 727-734.NLM
Pfeffer MA, McMurray J, Leizorovicz A, Maggioni AP, Rouleau J-L, Van de Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers MA, Velazquez E, Califf R. Valsartan in acute myocardial infarction trial (valiant): rationale and design. American Heart Journal. 2000 ; 140( 5): 727-734.[citado 2024 ago. 14 ]Vancouver
Pfeffer MA, McMurray J, Leizorovicz A, Maggioni AP, Rouleau J-L, Van de Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers MA, Velazquez E, Califf R. Valsartan in acute myocardial infarction trial (valiant): rationale and design. American Heart Journal. 2000 ; 140( 5): 727-734.[citado 2024 ago. 14 ]